Quantcast

Latest Haptoglobin Stories

2010-10-26 22:31:03

Type 1 diabetes (T1D), formerly known as juvenile diabetes, is a multifactorial disease of complex etiology characterized by the autoimmune destruction of pancreatic beta cells. In addition to genetic susceptibility, it is generally accepted that environmental factors play important roles in triggering disease, with virus infection having perhaps the strongest association. Multiple viral infections including cytomegalovirus, mumps, rubella, enteroviruses, and parvovirus have all been...

2009-09-07 14:39:01

Findings reveal further detail about protein linked to inflammatory disorders It was nine years ago that University of Maryland School of Medicine researchers discovered that a mysterious human protein called zonulin played a critical role in celiac disease and other autoimmune disorders, such as multiple sclerosis and diabetes. Now, scientists have solved the mystery of zonulin's identity, putting a face to the name, in a sense. Scientists led by Alessio Fasano, M.D., have identified zonulin...

2008-11-13 03:00:05

Synvista Therapeutics, a biopharmaceutical company, has announced new data demonstrating that discontinuation of vitamin E in patients with the Hp2-2 diabetes may result in an increased risk of heart attack and rapid deterioration of HDL function. In a prospective study called Icare, 2,241 individuals with diabetes mellitus age 55 or over from 47 primary-care clinics in Israel underwent haptoglobin (Hp) genotype testing and were randomized to receive either vitamin E or placebo. The...

2008-11-11 09:00:08

MONTVALE, N.J., Nov. 11 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. today announced new data demonstrating that discontinuation of Vitamin E in patients with the Hp2-2 Diabetes may result in an increased risk of heart attack and rapid deterioration of HDL function. These results were presented today at the Annual Scientific Sessions of the American Heart Association, underway in New Orleans. "These data demonstrate that after detecting Hp2-2 Diabetes, physicians modified...

2008-10-24 12:00:26

MONTVALE, N.J., Oct. 24 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. announced today that Noah Berkowitz, M.D., Ph.D., President and Chief Executive Officer of Synvista will present at the upcoming 2008 BIO Investor Forum on Thursday, October 30, at 8:30 a.m. Pacific Time. The event will be held October 29th - 31st at the Palace Hotel in San Francisco, California. Dr. Berkowitz will discuss the company's planned commercialization of its haptoglobin test kit for diabetes and...

2008-09-15 09:00:11

LOS ANGELES, Sept. 15 /PRNewswire/ -- Vista Partners announced today that it has updated coverage on Synvista Therapeutics, Inc. and maintains its $4.46 target price. Ross Silver, Director of Research of Vista Partners stated, "Several near term catalysts that investors should be aware of are the progression of the Haptoglobin diagnostic test - mainly the IDE meeting and its first sales in 2009. Recent positive news pertaining to the speed and efficacy of the diagnostic test kit should...

2008-09-11 09:00:09

MONTVALE, N.J., Sept. 11 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. today announced findings from a study that indicated Synvista's proprietary monoclonal enzyme immunoassay can determine a person's haptoglobin pheno/genotype in less than two hours, and can aid physicians in predicting cardiovascular risk in patients with diabetes. The study was presented today at the 2008 Cardiovascular Biomarkers and Surrogate Endpoints Symposium in Bethesda, Maryland. "This study shows the...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.